Replimune Group Inc. shares cratered after the U.S. Food and Drug Administration delivered a second, definitive rejection of its lead skin cancer therapy, trigg ...

Bloom Energy's stock is riding a wave of momentum, but a critical week ahead will test whether its ambitious growth narrative can withstand intense financial sc ...

Shares in German defense giant Rheinmetall tumbled sharply last Friday, shedding 5.4 percent to close at EUR 1,462.40. This ...

Healwell AI faces a key test as it reports Q1 2026 results after a transformative 2025 with 427% revenue growth and its first year of positive adjusted EBITDA.

The biotech sector is a study in contrasts, where a single regulatory decision can spell disaster for one firm while another methodically advances its pipeline.

Silver prices are being propelled by a potent combination of immediate geopolitical anxiety and a deepening structural ...

The stark divide between ServiceNow's operational performance and its stock price has never been wider. While the company ...

A dramatic shift in capital flows is reshaping the Bitcoin market, providing a powerful counterweight to persistent ...

OMV navigates oil market volatility, a major portfolio transformation, and a key investor reducing its stake, with Q1 2026 ...

Xiaomi's stock hits lows despite AI model success and strong EV orders, as tariffs, rising costs, and a profit squeeze ...

ABO Energy's stock shows a technical signal after an 85% plunge. While facing a massive 2025 loss, its renewable project ...

Amazon shares closed the week on a strong note, buoyed by a strategic pharmaceutical partnership and sustained momentum in its cloud division. The stock gained ...